Itonis, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ITNS research report →
Companywww.itonisholdings.com
Itonis, Inc. , a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea.
- CEO
- Mark H. Cheung
- IPO
- 2007
- Employees
- 3
- HQ
- Laguna Hills, CA, US
Price Chart
Valuation
- Market Cap
- $609.36K
- P/E
- -53.70
- P/S
- 3990.86
- P/B
- -0.53
- EV/EBITDA
- -145.80
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- -7432.44%
- Net Margin
- -7432.44%
- ROE
- 0.99%
- ROIC
- 11.41%
Growth & Income
- Revenue
- $152.69 · -55.61%
- Net Income
- $-11,322 · -17.59%
- EPS
- $0.00 · 0.00%
- Op Income
- $-11,322
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.35
- Avg Volume
- 131.68K
Get TickerSpark's AI analysis on ITNS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ITNS Coverage
We haven't published any research on ITNS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ITNS Report →